Intratympanic Gentamicin Therapy for Ménière’s Disease: A Meta-analysis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Otology and Neurotology

• Publication date

  2004-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00129492-200407000-00023PMID 15241234
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regression Modeling Strategies

  2003cited by this paper
• Efficacy of Increased Gentamicin Concentration for Intratympanic Injection Therapy in Ménière's Disease

  2002cited by this paper
• Continuous Gentamicin Therapy Using an IntraEAR Microcatheter for Meniere's Disease: A Retrospective Study

  2002cited by this paper
• Generalized Linear Models

  2002cited by this paper
• Facial nerve paralysis in temporal bone fractures: outcomes after late decompression surgery.

  2001cited by this paper
• Intratympanic Therapy for Me´nie`re's Disease: Effect of Administration of Low Concentration of Gentamicin

  2001cited by this paper
• Intratympanic Dexamethasone, Intratympanic Gentamicin, and Endolymphatic Sac Surgery for Intractable Vertigo in Meniere's Disease

  2001cited by this paper
• Long-Term Follow-Up of Transtympanic Gentamicin for Méniére's Syndrome

  2001cited by this paper
• Continuous Intratympanic Infusion of Gentamicin Via a Microcatheter in Menière's Disease

  2001cited by this paper
• Microdose Gentamicin Administration via the Round Window Microcatheter

  2001cited by this paper
• Intratympanic Gentamicin for the Treatment of Unilateral Meniere's Disease

  2000cited by this paper
• Preliminary results of a new delivery system for gentamicin to the inner ear in patients with Meniere’s disease

  2000cited by this paper
• Low-dose intratympanic gentamicin treatment for dizziness in Ménière's disease.

  2000cited by this paper
• Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.

  1999cited by this paper
• Intratympanic gentamicin titration therapy for intractable Meniere's disease.

  1999cited by this paper
• Intratympanic Therapy for Ménière's Disease: High‐Concentration Gentamicin with Round‐Window Protection

  1999cited by this paper
• The current role of local intratympanic gentamicin therapy in the management of unilateral Menière's disease.

  1998cited by this paper
• Intratympanic gentamicin injection for the treatment of Meniere's disease.

  1998cited by this paper
• Head and neck surgery

  1997cited by this paper
• Treatment of intractable Menière's disease with intratympanic gentamicin: review of the University of Ottawa experience.

  1997cited by this paper
• Intratympanic gentamicin therapy for Ménière's disease.

  1997cited by this paper
• Intratympanic Gentamicin for Treatment of Intractable Meniere's Disease: A Preliminary Report

  1997cited by this paper
• Low‐Dose Intratympanic Gentamicin and the Treatment of Meniere's Disease: Preliminary Results

  1997cited by this paper
• Intratympanic gentamicin therapy for meniere’s disease

  1997cited by this paper
• 9:24 AM: Discussion

  1996cited by this paper
• Intratympanic gentamicin therapy for Menière's disease: preliminary comparison of two regimens.

  1995cited by this paper
• Committee on Hearing and Equilibrium Guidelines for the Diagnosis and Evaluation of Therapy in Meniere's Disease ∗

  1995cited by this paper
• Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc.

  1995cited by this paper
• The influence of elective neck dissection on neck relapse in NO supraglottic carcinoma.

  1993cited by this paper
• Intratympanic gentamicin instillation as treatment of unilateral Menière's disease: update of an ongoing study.

  1993cited by this paper
• Treatment of Menière's disease with topical gentamicin: a preliminary report.

  1992cited by this paper
• Delayed onset of ototoxic effects of gentamicin in treatment of Menière's disease. Rationale for extremely low dose therapy.

  1991cited by this paper
• Delayed onset of ototoxic effects of gentamicin in treatment of Menière's disease.

  1991cited by this paper
• Intratympanic gentamycin in severe Ménière's disease.

  1990cited by this paper
• Middle ear ototoxic treatment for inner ear disease.

  1989cited by this paper
• Intratympanic application of gentamicin for treatment of Menière's disease.

  1986cited by this paper
• 10 Years of experience with intratympanally applied streptomycin (gentamycin) in the therapy of Morbus Menière

  1978cited by this paper
• Ablation therapy in the management of Menière's disease.

  1957cited by this paper
• Theory of point estimation

  1950cited by this paper
• Intratympanic Therapy in Meniere ’ s Disease

  year unknowncited by this paper

• Surgical treatment of vestibular disorders: a narrative review

  2025cites this paper
• The Top 100 Cited Articles in Otology and Neurotology and Analysis of Female Authorship.

  2025cites this paper
• Impact of repeated intranasal gentamicin irrigation on auditory brainstem evoked potentials in rats

  2024cites this paper
• Trends in Procedural Management of Meniere's Disease: Analysis of a National Insurance Claims Database

  2024cites this paper
• Intratympanic gentamicin for Ménière’s disease

  2023influential citation
• Efficacy and preservation of hearing with low-dose gentamicin in unilateral meniere's disease: A clinical symptomatology-based study.

  2023cites this paper
• LETTER TO THE EDITOR FOR THE ARTICLE "ENDOSCOPIC TRANSCANAL LABYRINTHECTOMY FOR INTRACTABLE MENIERE'S DISEASE: AN ALTERNATIVE TO TRANSMASTOID LABYRINTHECTOMY".

  2022cites this paper
• RESPONSE TO LETTER TO THE EDITOR: "ENDOSCOPIC TRANSCANAL LABYRINTHECTOMY FOR INTRACTABLE MENIÈRE'S DISEASE: AN ALTERNATIVE TO TRANSMASTOID LABYRINTHECTOMY".

  2022cites this paper
• Low-Dose Intratympanic Gentamicin for Unilateral Ménière‘s Disease: Accuracy of Early Vestibulo-Ocular Reflex Gain Reduction in Predicting Long-Term Clinical Outcome

  2022cites this paper
• Duration of symptom control following intratympanic dexamethasone injections in Meniere’s disease

  2022cites this paper
• Intratympanic gentamicin injections

  2021cites this paper
• Current and Emerging Medical Therapies for Dizziness.

  2021cites this paper
• Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: A meta-analysis.

  2021cites this paper
• Endoscopic Transcanal Labyrinthectomy for Intractable Meniere's Disease: An Alternative to Transmastoid Labyrinthectomy?

  2021cites this paper
• Association between Meniere’s disease and air pollution in South Korea

  2021cites this paper
• Intratympanic aminoglycosides for Ménière’s disease

  2021cites this paper
• Comparing Intratympanic Gentamicin with Methylprednisolone in Meniere’s Disease with Non-Serviceable Hearing

  2021cites this paper
• Meniere's disease: Medical management, rationale for vestibular preservation and suggested protocol in medical failure.

  2020cites this paper
• On-Demand and Low Dose Intratympanic Gentamicin for Meniere's Disease: A Customized Approach.

  2020influential citation
• A Case of Tumarkin Otolithic Crisis Treated with Intratympanic Gentamicin Injection

  2020cites this paper
• Clinical Practice Guideline: Ménière’s Disease

  2020cites this paper
• Drugs inducing hearing loss, tinnitus, dizziness and vertigo: an updated guide.

  2020cites this paper
• Low Dose Intratympanic Gentamicin in Ménière’s Disease

  2020cites this paper
• INTRATYMPANIC LOW DOSE GENTAMICIN IN INTRACTABLE MENIERE’S DISEASE- CHEMICAL LABYRINTHECTOMY REVISITED

  2019cites this paper
• Intratympanic gentamicin injection for Meniere's disease

  2019cites this paper
• Low-dose intratympanic gentamicin administration for unilateral Meniere's disease using a method based on clinical symptomatology: Preliminary results.

  2019cites this paper
• A comparison of endolymphatic shunt surgery and intratympanic gentamicin for meniere's disease

  2019influential citation
• Long-term Vertigo Control and Vestibular Function After Low-dose On-demand Transtympanic Gentamicin for Refractory Menière's Disease.

  2019cites this paper
• Uso de gentamicina transtimpánica: Experiencia del Hospital Clínico de la Universidad de Chile

  2019cites this paper
• The Clinical Outcomes After Intratympanic Gentamicin Injection to Treat Menière's Disease: A Meta-analysis.

  2019cites this paper
• Therapeutic strategies in the treatment of Menière's disease: the Italian experience

  2019cites this paper
• The Treatment of Meniere’s Disease by the Intratympanic Therapy

  2019cites this paper
• Different medications for the treatment of Ménière's disease by intratympanic injection: A systematic review and network meta‐analysis

  2019cites this paper
• Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease.

  2019cites this paper
• Fluctuating Sensorineural Hearing Loss

  2019cites this paper
• Intratympanic / Transtympanic Gentamicin Treatment for Meniere ' s Disease

  2018cites this paper
• Low Concentration Intra-Tympanic Gentamicin Treatment for Menière's Disease: A Long-Term Follow Up.

  2018cites this paper
• Intratympanic Therapies in Ménière Disease: Evaluation of Outcomes and Early Vertigo Control

  2018cites this paper
• Instrumental head impulse test changes after intratympanic gentamicin for unilateral definite Ménière's disease: A systematic review and meta-analysis.

  2018cites this paper
• The future of inner ear drug delivery

  2018cites this paper
• Contrôle des vertiges dans la maladie de Menière par injections trans-tympaniques de dexaméthasone

  2018cites this paper
• Gentamicin delivery to the inner ear: Does endolymphatic hydrops matter?

  2018cites this paper
• Malattia di Menière

  2018cites this paper
• Enfermedad de Menière

  2018cites this paper
• Maladie de Menière

  2017cites this paper
• Intratympanic (IT) Therapies for Menière’s Disease: Some Consensus Among the Confusion

  2017cites this paper
• Efficacy of Intratympanic Gentamicin in Menière's Disease With and Without Migraine.

  2017cites this paper
• Gentamicin Applied to the Oval Window Suppresses Vestibular Function in Guinea Pigs

  2017cites this paper
• Endolymphatic Sac Surgery for Ménière's Disease – Current Opinion and Literature Review

  2017cites this paper
• Is gentamycin delivery via sustained-release vehicles a safe and effective treatment for refractory Meniere’s disease? A critical analysis of published interventional studies

  2017cites this paper
• Cochlear and Vestibular Effects of Combined Intratympanic Gentamicin and Dexamethasone.

  2017cites this paper
• Intratympanic Triamcinolone and Dexamethasone in the Treatment of Ménière's Syndrome.

  2017cites this paper
• Advances in nano‐based inner ear delivery systems for the treatment of sensorineural hearing loss☆

  2017cites this paper
• Diagnostic and therapeutic strategy in Menière's disease. Guidelines of the French Otorhinolaryngology-Head and Neck Surgery Society (SFORL).

  2017cites this paper
• Recommandations de la SFORL (version courte) sur la stratégie diagnostique et thérapeutique dans la maladie de Menière

  2017cites this paper
• Control of vertigo in Ménière's disease by intratympanic dexamethasone.

  2017cites this paper
• Endolymphatic sac drainage for the treatment of Ménière's disease

  2016cites this paper
• anica en el tratamiento de patolog´õa de o´õdo interno

  2016cites this paper
• Exploratory tympanotomy and gentamicin application in patients with intractable Meniere’s Disease

  2016cites this paper
• V´ ia intratimp anica en el tratamiento de patolog´ ia de o´ ido interno

  2016cites this paper
• Meniere's disease

  2016cites this paper
• Intratympanic dexamethasone in Meniere’s disease

  2016cites this paper
• Refractory episodic vertigo: role of intratympanic gentamicin and vestibular evoked myogenic potentials

  2016cites this paper
• Vestibular results after intratympanic gentamicin therapy in disabling Menière’s disease

  2016cites this paper
• Utility of Drug Loaded Nanoparticles in the Treatment of Inner Ear Pathology

  2016cites this paper
• Ménière’s Disease

  2016cites this paper
• UNILATERAL MENIERE’S DISEASE; INTRA TYMPANIC INJECTION OF LOW DOSE GENTAMICIN IN THE TREATMENT

  2016cites this paper
• Histopathologic Changes of the Inner ear in Rhesus Monkeys After Intratympanic Gentamicin Injection and Vestibular Prosthesis Electrode Array Implantation

  2015cites this paper
• Morbus Menière

  2015cites this paper
• Management of intractable Ménière's disease after intratympanic injection of Gentamicin

  2015cites this paper
• Is low-dose intratympanic gentamicin an effective treatment for Ménière's disease: the Birmingham experience

  2015cites this paper
• Surgery for vertigo: 10-year audit from a contemporary vertigo clinic.

  2015cites this paper
• Systematic review and meta‐analysis of meniett therapy for Meniere‐s disease

  2015cites this paper
• Intratympanic therapy in Meniere's syndrome or disease: up to date evidence for clinical practice

  2015cites this paper
• Chemical labyrinthectomy for the worse ear of adult Nigerians with bilateral Meniere’s disease: preliminary report of treatment outcomes

  2015cites this paper
• Intratympanic dexamethasone injections for refractory Meniere' s disease.

  2015cites this paper
• Endolymphatic Sac Surgery for Meniere's Disease

  2014cites this paper
• Comparison of second-echelon treatments for Ménière's disease.

  2014cites this paper
• Meniere’s disease

  2014cites this paper
• Intratympanic gentamicin treatment ‘as needed’ for Meniere’s disease. Long-term analysis using the Kaplan–Meier method

  2014cites this paper
• One-shot, low-dosage intratympanic gentamicin for Ménière's disease: Clinical, posturographic and vestibular test findings

  2014cites this paper
• The Predominant Vestibular Uptake of Gadolinium Through the Oval Window Pathway Is Compromised by Endolymphatic Hydrops in Ménière’s Disease

  2014cites this paper
• Middle Ear Gentamicin-Soaked Pledgets in the Treatment of Ménière’s Disease

  2014cites this paper
• TITLE : Treatments for Meniere ’ s Disease SOURCE : Grand Rounds Presentation , UTMB , Dept . of Otolaryngology DATE : December 13 , 2006 RESIDENT PHYSICIAN :

  2014cites this paper
• Intratympanic gentamicin as a treatment for drop attacks in patients with Meniere's disease

  2014cites this paper
• Intratympanic Gentamicin for Ménière’s Disease

  2014cites this paper
• Intratympanic gentamicin treatment for Ménière’s disease: a randomized, double-blind, placebo-controlled trial on dose efficacy - results of a prematurely ended study

  2014cites this paper
• Intratympanic Therapies for Menière’s Disease

  2014cites this paper
• Meniere’s Disease

  2013cites this paper
• A regulated delivery system for inner ear drug application.

  2013cites this paper
• Dynamic Change of VOR and Otolith Function in Intratympanic Gentamicin Treatment for Ménière's Disease: Case Report and Review of the Literature

  2013influential citation
• Inner ear disorders

  2013cites this paper
• The Effect of Intratympanic Methylprednisolone and Gentamicin Injection on Ménière’s Disease

  2013cites this paper
• Response to: Comparison of Intratympanic Methylprednisolone and Gentamicin for Ménière’s Disease May Be Misleading

  2013cites this paper
• Evaluation of Two Procedures of Intratympanic Gentamicin Therapy in Meniere ’ s Disease

  2013cites this paper
• Gentamicin Concentration Gradients in Scala Tympani Perilymph following Systemic Applications

  2013cites this paper
• Control of Vertigo After Intratympanic Corticoid Therapy for Unilateral Ménière’s Disease: A Comparison of Weekly Versus Daily Fixed Protocols

  2013cites this paper
• Distribution of Gentamicin in Inner Ear after Local Administration via a Chitosan Glycerophosphate Hydrogel Delivery System

  2012cites this paper
• Oval Window Transport of Gd-DOTA from Rat Middle Ear to Vestibulum and Scala Vestibuli Visualized by in vivo Magnetic Resonance Imaging

  2012cites this paper
• Microsystems technologies for drug delivery to the inner ear.

  2012cites this paper